We are monitoring the impact of COVID-19 on Europe Renal Biomarkers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5223
Share on
Share on

Europe Renal Biomarkers Market Research Report - Segmented By Diagnostic Technique, Type & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 5223
Pages: 145

Europe Renal Biomarkers Market Size (2020 to 2025)

The size of the European Renal Biomarkers market is forecasted to grow at a prominent CAGR during the forecast period. Europe is assumed as a developed market and is anticipated to witness significant growth in the forecast period.

The uplift in research and development activities for renal biomarkers, rising healthcare infrastructure, and escalating medical tourism impels the renal biomarkers market growth in Europe. 

Growing pediatric suffering from renal diseases and government supports with funds are driving the market growth. The renal biomarkers market growth is driven by factors like the rising geriatric population and increasing demand for innovative healthcare products. Extensive usage in different diagnostic processes at reasonably low cost is commanding the growth of renal biomarkers in Europe. A high amount spent by the population on healthcare, development of personalized medicine for treating chronic kidney diseases, and early diagnosis of renal cancer may stop disease progression, which in turn escalates the renal biomarkers market growth in the region during the analysis period.

Difficulties associated with regulatory bodies and low reimbursement schemes are the factors impeding the market growth in Europe. No proper way or sufficient identification for examining acute and chronic kidney diseases is hampering the European renal biomarkers market.

This research report on the Europe Renal Biomarkers Market has been segmented and sub-segmented into the following categories:

  • By Diagnostic Technique: Chemiluminescent Enzyme Immunoassay, Colorimetric Assay, Enzyme-Linked Immunosorbent Assay, Liquid Chromatography-Mass Spectrometry, Particle-Enhanced Turbidimetric Immunoassay
  • By Type: Up-Regulated Proteins, Interleukin 18, Kidney injury molecule 1, Neutrophil gelatinase-associated lipocalin, Functional Biomarker, Serum Creatinine, Serum Cystatin C, Urine Albumin.

By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.Regional Analysis:

The market size of the renal biomarkers in Europe is estimated to grow with a high CAGR during the historical period from 2020 to 2025. Factors like the rising incidence of chronic kidney diseases like Acute Kidney Injury (AKJ), nephropathies, and drug-induced kidney toxicities leading to the enhancement of new renal biomarkers in regulating disease progression rate. The increasing occurrence rate of renal diseases and high blood pressure is escalating the growth of the market.

The UK is top in the region with the largest market share because of quick introduction and innovations in the market and equipment domain. A considerable increase in the aging population and booming dominance of disease illness, and a thriving interest in innovative work and investments in R&D will propel the market further.  

Germany, France, Italy, and the rest of Europe are anticipated to have subsequent growth in the market of the region due to quick advances in genetics that tends to the development of advanced renal biomarkers in treating kidney diseases, strengthening the increase in the area.

Prominent Companies dominating the Europe Renal Biomarkers Market Profiled in the Report are Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Astute Medical Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Alere Inc., bioMérieux SA, and Randox Laboratories Ltd.

1. Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Diagnostic Technique    

       5.1.1 Introduction           

       5.1.2 Chemiluminescent Enzyme Immunoassay

       5.1.3 Colorimetric Assay               

       5.1.4 Enzyme-Linked Immunosorbent Assay       

       5.1.5 Liquid Chromatography-Mass Spectrometry            

       5.1.6 Particle-Enhanced Turbidimetric Immunoassay      

       5.1.7  Y-o-Y Growth Analysis, By Diagnostic Technique   

       5.1.8  Market Attractiveness Analysis, By Diagnostic Technique

       5.1.9  Market Share Analysis, By Diagnostic Technique   

                5.2 Type     

       5.2.1 Introduction           

       5.2.2 Up-Regulated Proteins      

                       5.2.2.1 Interleukin 18

                       5.2.2.2 Kidney injury molecule 1

                       5.2.2.3 Neutrophil gelatinase-associated lipocalin

       5.2.3 Functional Biomarker         

                       5.2.3.1 Serum Creatinine

                       5.2.3.2 Serum Cystatin C

                       5.2.3.3 Urine Albumin

       5.2.4 Others      

       5.2.5 Y-o-Y Growth Analysis, By Type     

       5.2.6 Market Attractiveness Analysis, By Type   

       5.2.7 Market Share Analysis, By Type     

                5.3 End User                      

       5.3.1 Introduction           

       5.3.2 Diagnostic Labs      

       5.3.3 Hospitals  

       5.3.4 Outpatient Clinics 

       5.3.5 Research Centres 

       5.3.6 Y-o-Y Growth Analysis, By End User             

       5.3.7  Market Attractiveness Analysis, By End User          

       5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Diagnostic Technique

                       6.1.3.3 By Type

                       6.1.3.4 By End User

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Diagnostic Technique

                       6.1.4.3 By Type

                       6.1.4.4 By End User

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Diagnostic Technique

                       6.1.5.3 By Type

                       6.1.5.4 By End User

                6.2 U.K                 

                6.3 Spain    

                6.4 Germany                     

                6.5 Italy      

                6.6 France

                6.7 Rest of Europe 

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 Thermo Fisher Scientific Inc                 

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Abbott Laboratories      

                8.3 Beckman Coulter, Inc.   

                8.4 Randox Laboratories Ltd                       

                8.5 Astute Medical Inc.                 

                8.6 F. Hoffmann-La Roche AG                    

                8.7 Siemens Healthcare Diagnostics Inc.                

                8.8 Alere Inc.                     

                8.9 bioMérieux SA

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Diagnostic Technique and Type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Renal Biomarker Market By Diagnostic Technique, From 2020-2025 ( USD Million )
  2. Europe Enzyme Linked Immunosorbent Assay Market By Region, From 2020-2025 ( USD Million )
  3. Europe Chemiluminescent Enzyme Immunoassay Market By Region, From 2020-2025 ( USD Million )
  4. Europe Colorimetric Assay Market By Region, From 2020-2025 ( USD Million )
  5. Europe Liquid Chromatography-Mass Spectrometry Market By Region, From 2020-2025 ( USD Million )
  6. Europe Particle-Enhanced Turbidimetric Immunoassay Market By Region, From 2020-2025 ( USD Million )
  7. Europe Renal Biomarker Market By Biomarker Type, From 2020-2025 ( USD Million )
  8. Europe Up-Regulated Proteins Market By Region, From 2020-2025 ( USD Million )
  9. Europe Functional Biomarker Market By Region, From 2020-2025 ( USD Million )
  10. Europe Renal Biomarker Market By End User, From 2020-2025 ( USD Million )
  11. Europe Diagnostic Labs Market By Region, From 2020-2025 ( USD Million )
  12. Europe Hospitals Market By Region, From 2020-2025 ( USD Million )
  13. Europe Outpatient Clinics Market By Region, From 2020-2025 ( USD Million )
  14. Europe Research Centres Market By Region, From 2020-2025 ( USD Million )
  15. U.K. Renal Biomarker Market By Diagnostic Technique, From 2020-2025 ( USD Million )
  16. U.K. Renal Biomarker Market By Biomarker Type, From 2020-2025 ( USD Million )
  17. U.K. Renal Biomarker Market By End User, From 2020-2025 ( USD Million )
  18. Germany Renal Biomarker Market By Diagnostic Technique, From 2020-2025 ( USD Million )
  19. Germany Renal Biomarker Market By Biomarker Type, From 2020-2025 ( USD Million )
  20. Germany Renal Biomarker Market By End User, From 2020-2025 ( USD Million )
  21. France Renal Biomarker Market By Diagnostic Technique, From 2020-2025 ( USD Million )
  22. France Renal Biomarker Market By Biomarker Type, From 2020-2025 ( USD Million )
  23. France Renal Biomarker Market By End User, From 2020-2025 ( USD Million )
  24. Italy Renal Biomarker Market By Diagnostic Technique, From 2020-2025 ( USD Million )
  25. Italy Renal Biomarker Market By Biomarker Type, From 2020-2025 ( USD Million )
  26. Italy Renal Biomarker Market By End User, From 2020-2025 ( USD Million )
  27. Spain Renal Biomarker Market By Diagnostic Technique, From 2020-2025 ( USD Million )
  28. Spain Renal Biomarker Market By Biomarker Type, From 2020-2025 ( USD Million )
  29. Spain Renal Biomarker Market By End User, From 2020-2025 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample